The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes
Open accessAbstract
CONTEXT: Gastric bypass surgery (GBP) results in rapid weight loss, improvement of type 2 diabetes (T2DM), and increase in incretins levels. Diet-induced weight loss also improves T2DM and may increase incretin levels. OBJECTIVE: Our objective was to determine whether the magnitude of the change of the incretin levels and effect is greater after GBP compared with a low caloric diet, after equivalent weight loss. DESIGN AND METHODS: Obese women with T2DM studied before and 1 month after GBP (n = 9), or after a diet-induced equivalent weight loss (n = 10), were included in the study. Patients from both groups were matched for age, body weight, body mass index, diabetes duration and control, and amount of weight loss. SETTING: This outpatient study was conducted at the General Clinical Research Center. MAIN OUTCOME MEASURES: Glucose, insulin, proinsulin, glucagon, gastric inhibitory peptide (GIP), and glucagon-like peptide (GLP)-1 levels were measured after 50-g oral glucose. The incretin effect was measured as the difference in insulin levels in response to oral and to an isoglycemic iv glucose load. RESULTS: At baseline, none of the outcome variables (fasting and stimulated values) were different between the GBP and diet groups. Total GLP-1 levels after oral glucose markedly increased six times (peak:17 +/- 6 to 112 +/- 54 pmol/liter; P < 0.001), and the incretin effect increased five times (9.4 +/- 27.5 to 44.8 +/- 12.7%; P < 0.001) after GBP, but not after diet. Postprandial glucose levels (P = 0.001) decreased more after GBP. CONCLUSIONS: These data suggest that early after GBP, the greater GLP-1 and GIP release and improvement of incretin effect are related not to weight loss but rather to the surgical procedure. This could be responsible for better diabetes outcome after GBP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have established that the incretin effect, β-cell secretion activated by eating, is increased in GB patients with type 2 diabetes (6,9).”
From Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans (2011) · cites this paper as [9]
In the citing paper
“Previous studies have reported that glucagon secretion after GB is elevated after meal ingestion (9,16,25)”
From Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans (2011) · cites this paper as [9]
In the citing paper
“GB subjects have elevated plasma concentrations of GLP-1 (6,8–13).”
From Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans (2011) · cites this paper as [9]
In the citing paper
“These findings suggest that the relatively higher postprandial insulin responses seen in patients after GB (8,9,12,23) are not a response to insulin resistance or the result of general hypersensitivity of β-cells to glucose.”
From Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans (2011) · cites this paper as [9]
In the citing paper
“this obesity-independent hypoglycemic effect has been related to the action of GLP-1 in promoting insulin section [3], [6].”
From Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models (2013) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
Hedley, A. A., Ogden, C., Johnson, C. L., Carroll, M., Curtin, L. R., & Flegal, K. (2004) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.291.23.2847 · Cited by 4,670
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Trends in mortality in bariatric surgery: a systematic review and meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., & Sledge, I. (2007) · Surgery · doi:10.1016/j.surg.2007.07.018 · Cited by 685
Sjöström, C. D., Lissner, L., Wedel, H., & Sjöström, L. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00436.x · Cited by 685
Research works printed but not linked: 1
- Laferrère, 2007, The increase in GLP-1 levels and incretin effect after Roux-en-Y gastric bypass surgery (RYGBP) persists up to 1 year in patients with type 2 diabetes mellitus (T2DM), Obesity, 15, 7
Cited by
Sorted by citations
Items 601–678 of 678
Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E. H., Salvador, J., & Still, C. D. (2010)
Maigreur et résistance à la prise de poids : la preuve du concept
Germain, N., Galusca, B., & Estour, B. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30006-2 · Cited by 1
On the Impact of Bariatric Surgery on Glucose Homeostasis
Abrahamsson, N. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Bariatric Surgery: An Attractive Therapeutic Modality for Type 2 Diabetes Mellitus
Dugum, M. F., El-Hayek, K. M., & Garg, S. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0150
“Furthermore, this increased secretion is not the result of the weight reduction alone, as it is much more marked following surgery compared with similar weight loss from caloric restriction alone.(15) Following numerous observational studies pointing to the role of bariatric surgery in hyperglycemia remission, several…”
Resultde Vista, P., Ceneviva, R., Viegas-Silva, M. M., dos Santos, J. S., Júnior, W. S., & Silva, O. D. C. E. (2011)
48 Effects of Bariatric Surgery on Diabetes
Soni, A., Shukla, A. P., & Rubino, F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1637-5_48
Bariatric Surgery or Medical Therapy for Obesity
Frontoni, S., Malandrucco, I., & Bonadonna, R. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1206633
The Role of Incretins in Insulin Secretion
Salehi, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_4-1
Malin, S. K., & Kashyap, S. R. (2016)
Impact of bariatric surgeries on diabetes outcomes
Muscelli, E., & Alecrim, H. M. (2014)
Nicht immer ist Diabetesremission dauerhaft
Konz, K. (2013) · Info Diabetologie · doi:10.1007/s15034-013-0426-0
and unchanged glucose effectiveness in patients with type 2 diabetes
Martinussen, C., Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Kristiansen, V. B., Holst, J. J., & Madsbad, S. (2015)
From Bariatric surgery to Metabolic surgery
Caiazzo, R. J., Arnalsteen, L., & Pattou, F. N. (2010)
Osorio, R. L., & Hastedt, P. (2015) · World Journal of Laparoscopic Surgery with DVD · doi:10.5005/jp-journals-10007-1252
Bariatric Surgery Improves Type 2 Diabetes Mellitus
Greve, J.-W. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804011-9.00052-2
Nature Reviews UNCORRECTED PROOF
Aron‐Wisnewsky, J., Dore, J. M., & Clément, K. (2012)
Perioperative physiology and optimalisation in bariatric and metabolic surgery
Pouwels (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170531sp
Alleotti, E., Engler, P., Júnior, P., Bento, J. A., Campos, C. G., Waisberg, J., Paulo-SP, S., & André-SP, S. (2012)
Der Magenbypass — eine Chance auf Diabetesremission mit Haken und Ösen
Franke-Ullmann, G., & Simon, M. (2017) · Info Diabetologie · doi:10.1007/s15034-017-0974-9
A Brief History of Bariatric Surgery to the Present
Deitel, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-76177-0_1
Effetti metabolici della chirurgia bariatrica
Savastano, S., Barrea, L., Belcastro, S., & Broglio, F. (2017) · L Endocrinologo · doi:10.1007/s40619-017-0349-4
“Inoltre, la riduzione di ghrelin osservata sia post SG che RYGB, è stata suggerita come uno dei meccanismi responsabili dell’incremento post-chirurgico del senso di sazietà [16]; – il microbiota intestinale: la malattia diabetica e quella cardiovascolare sono entrambe associate a un’infiammazione cronica di basso grad…”
BackgroundCalorie Restriction and Insulin Sensitivity in Obesity
Shah, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-40007-5_82-1
Bile Acids and FGF19 in the Remission of Type 2 Diabetes After Sleeve Gastrectomy and Gastric Bypass
Nemati, R. (2017) · Tuwhera (Auckland University of Technology)
Hussan, H., Ugbarugba, E. E., Krishna, S. G., Conwell, D. L., Bradley, D. P., Steven, C. K., & NEEDLEMAN, B. J. (2017) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000356
“This increase occurs in a dose dependent manner in relation to dietary calorie content and is likely due to RYGB anatomical changes, as opposed to the subsequent weight loss, as the increase occurs prior to significant weight loss [45-47].”
BackgroundEvolução da insulinorresistência em doentes submetidos a cirurgia bariátrica
Areias, M., Neves, O., Poínhos, R., Oliveira, B. M. P. M., & Correia, F. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
Langer, I., & Brändle, M. (2010) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2010.07076
Surgical management of diabetes mellitus: future outlook (part 3)
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723354-64
Adipose markers of metabolic outcome after weight loss
Hogling, D. E. (2019) · Figshare
Staikov, P., Кryvoruchko, І. А., Parkhomenko, K. Y., Syvozhelіzov, A. V., Сикал, М. О., Smetskov, D. A., & Тонкоглас, А. А. (2019) · Journal of Education Health and Sport · doi:10.12775/jehs.2019.09.11.017
Gastric Bypass in Patients with Metabolic Syndrome
Palermo, M., Quevedo, M. D. P., Serra, E. E., & Ackermann, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-28803-7_45
Diabetes remission after bariatric surgery: Which are the mechanisms?
Caixàs, A. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.01.002
Caiazzo, R., Baud, G., & Pattou, F. N. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75879-9.00005-6
Effect of laparoscopic sleeve gastrectomy on blood sugar and blood pressure
Al-Basri, R. J. (2019) · AL-Kindy College Medical Journal · doi:10.47723/kcmj.v15i1.88
¿Es la diabetes tipo 2 una enfermedad tratable quirúrgicamente?
Romero-Ibarguengoitia, M. E. (2009) · Lux Médica · doi:10.33064/11lm20091691
Impact of Bariatric Surgery on Circulating Inflammatory and Pro-vascular Progenitor Cell Populations
Trac, J. Z. (2020) · TSpace (University of Toronto)
김유나, 이연희, & Kim, C. H. (2014)
Laparoscopic OAGB/MGB: Mechanism of Action
Ahuja, A., & Mahawar, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-54064-7_87-1
The Role of Bariatric Surgery in Obese Patients with Diabetes
Gandikota, P., & Laferrère, B. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch18
Ingenuos y generosos socialismos
Muru, V. M. A. (1976) · El Ciervo: revista mensual de pensamiento y cultura
Cirurgia bariátrica e exérese de tecido adiposo visceral (omentectomia)
Lima, M. M. D. O. (2015) · doi:10.47749/t/unicamp.2015.946312
Sayda, M. H., Aziz, M. H. A., Gharahdaghi, N., Wilkinson, D. J., Greenhaff, P. L., Phillips, B. E., Smith, K., Atherton, P. J., & IDRIS, I. R. (2022) · Research Square · doi:10.21203/rs.3.rs-1272404/v1
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833118e2
The Role of Incretins in Insulin Secretion
Salehi, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_4
Rubino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-15356-8_9
Is the gut the key to obesity?
Verdam, F. J. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120601fv
Treatment of Obesity in the Patient with Type 2 Diabetes
Mundi, M. S., & Collazo–Clavell, M. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_43
Änderungen der Betazellfunktion nach einer Magenbypassoperation
Jecht, M. (2022) · Der Diabetologe · doi:10.1007/s11428-022-00877-6
Early Phase Metabolic Research with Reference to Special Populations
Morrow, L., & Krentz, A. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_20
Laferrère, B. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.03.001
Can Bariatric Surgery be Considered Standard Therapy to Treat Type 2 Diabetes?
Meyvis, K., Block, C. E. M. D., Gaal, L. F. V., Endocrinologist, & Medicine, A. P. O. (2013) · US Endocrinology · doi:10.17925/use.2013.09.02.108
Amouyal, C., & Moutel, S. (2016) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(16)76382-3
Surgical Management for Diabetes Remission
Hurtado, A. M. D., & Collazo–Clavell, M. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_11
L’intestin un organe endocrine : de la physiologie aux implications thérapeutiques en nutrition
Beyec, J. L., Ledoux, S., Coëffier, M., & Gall, M. L. (2022) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2021.12.179 · Cited by 2
Mechanism of metabolic surgery for the treatment of Type 2 Diabetes Mellitus (T2DM)
Leishman, D. J., Ikramuddin, S., & Naitoh, T. (2023) · Mini-invasive Surgery · doi:10.20517/2574-1225.2023.29
Strategie di mantenimento del calo ponderale nel paziente con obesità
Verde, L., Muscogiuri, G., Colao, A., & Barrea, L. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01325-3
“correlati al CP, ma piuttosto alla procedura chirurgica [14].”
Enteroendocrine Reprogramming by Altered Epithelial-Mesenchymal Crosstalk in Metabolic Surgery
Hur, K. Y. (2024) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2024.13.1.1
“However, despite separating the high K-cell density area from nutrients, there is an increased GIP value of RYGB with a short BP limb [27,28].”
BackgroundHüttl, T. P., & Dietl, O. (2024) · Springer eBooks · doi:10.1007/978-3-662-58895-6_46
Foundations of Bariatric Surgery
Corpodean, F., Kachmar, M., Albaugh, V. L., & Schauer, P. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_2
Goodarzi, S., Shafiee, A., Rafiei, M. A., Dehbozorgi, M., Mofidi, A., Mirzaei, A., Mirzaei, S., & Soltanattar, A. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07952-z
Crespo, A. D. F. C. B., Antonângelo, L., Estabile, P. C., de Cleva, R., & Santo, M. A. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100736
Mittendorfer, B., Patterson, B. W., Eagon, J. C., Yoshino, M., & Klein, S. (2025) · Diabetes · doi:10.2337/db25-0737
Mechanisms of Bariatric Surgery
Miras, A. D., & le Roux, C. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_10
Surgical Approaches and Outcome in the Treatment of the Obese Patients
Wolfe, B. M., Blackburn, G. L., & Sanchez, V. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1203-2_17
Rouquet, T. (2015) · theses.fr (ABES) · doi:10.70675/680971a6z149ez4296z9c76z5ee9dfd53ce5
Restaurer la fonction bêta pancréatique de la souris leptine déficiente par la chirurgie bariatrique
Amouyal, C. (2019) · theses.fr (ABES) · doi:10.70675/57e90c8dz951az4b06z95cdzc78f34db6015
Vuorela, L., Berntzen, B. J., Muniandy, M., Saarinen, T., Meriläinen, S., Koivukangas, V., Suojanen, L.-U., Groop, P.-H., Rissanen, A., Virtanen, K. A., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346240
“This divergence may reflect physiology: satiety hormones [e.g., glucagon like peptide 1 [45,46], peptide YY [45,47,48], and cholecystokinine [45,47]] increase after bariatric surgery but remain unchanged or decrease after lifestyle-induced weight loss.”
Reliability of the Overnight Dexamethasone Suppression Test in Patients Undergoing Bariatric Surgery
Çapar, M. U., Durcan, E., Şahin, S., Kadıoğlu, P., Gönen, M. S., Yumuk, V., Damcı, T., Taşkın, H. E., Konukoğlu, D., Erçetin, C., et al. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08755-6
Pileggi, C. A., Mohottalage, D., Kennedy, L. S., Nikpay, M., Hamilton, L. M. K., Roffé, M., Kanaan, M. N., Jarrar, A., Kolozsvari, N., Wang, D., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106410
Can Leptin Responsiveness Be Restored in Common Human Obesity?
Janssen, J. A. M. J. L. (2026) · Lipidology · doi:10.3390/lipidology3030024
Johansson, H.-E. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Shahriarirad, R., Kalhor, P., Aslahishahri, M., Ghusn, W., Attia, Z. I., Ghazal, N. E., Ghanem, O. M., & Laplante, S. J. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08945-2
“…demonstrated that gastric bypass was associated with a sixfold increase in postprandial GLP-1 compared with equivalent diet-induced weight loss [ 28], with GLP-1 receptor agonism exerting pleiotropic anti-inflammatory, anti-oxidative, and anti-apoptotic effects that extend far beyond glycemic…”
Efectos metabólicos de la Gastrectomía vertical en un modelo de rata diabética no obesa
Manrique, M. A. M. (2013) · doi:10.35376/10324/3820
de Jonge, C. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140905cj
Malin, S. K., & Kirwan, J. P. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_16
Metadata
- Authors
- Laferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., Yapp, K., & Olivan, B.
- Affiliations
- Obesity Research Center (B.L., H.T., J.R.E., A.C., B.K., B.B., K.Y., B.O.), St. Luke’s/Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York 10025
- Bariatric Division (J.T., J.M., N.K., H.L.), St. Luke’s/Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York 10025
- St. Luke's-Roosevelt Hospital Center (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2479-2485
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2453054
- OpenAlex
- W2146737709
- Cited by
- 682
- References
- 57
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 18 · 2022: 17 · 2021: 25 · 2020: 25 · 2019: 39 · 2018: 21 · 2017: 45 · 2016: 48 · 2015: 44 · 2014: 57 · 2013: 72 · 2012: 59
- FWCI
- 63.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 67561, DK63068-05, DK 26687, R01DK067561, P30DK026687)
- National Center for Research Resources (UL1RR024156)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gastric bypass, type 2 diabetes, weight loss, incretin effect, glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, proinsulin, glucagon, insulin, postprandial blood glucose, hypocaloric diet, obesity, women
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Diet, Reducing, Female, Gastric Inhibitory Polypeptide, Glucagon, Humans, Male, Middle Aged, Obesity, Gastric Bypass, Weight Loss, Glucagon-Like Peptide 1, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
